在乳腺癌治疗中,蛋白质分解向化马体 (PROTACs)
1Department of Chemistry, Pusan National University, Busan, 46241, Korea.
ChemMedChem
|August 13, 2024
概括
针对蛋白质分解的嵌合体 (PROTACs) 通过降解引起疾病的蛋白质,为乳腺癌 (BC) 提供了一种新的治疗策略. 本综述探讨了PROTAC当前的发展,局限性和BC治疗的未来潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 乳腺癌 (BC) 是一个重大的全球健康挑战,占全球女性癌症病例的30%.
- 迫切需要选择性和有效的BC疗法,推动研究创新的治疗方式.
- 针对蛋白质溶解的嵌合体 (PROTACs) 由于其独特的作用机制,已成为BC的有希望的治疗策略.
研究的目的:
- 审查目前针对乳腺癌开发的PROTACs的现状.
- 根据他们针对的特定类型的乳腺癌,对现有的PROTAC进行分类.
- 讨论PROTAC技术在乳腺癌治疗的局限性和未来前景.
主要方法:
- 对现有的PROTAC分子及其在乳腺癌研究中的应用进行文献综述.
- 分析PROTAC的设计,包括目标蛋白质连接体,E3连接体和结合连接体.
- 基于乳腺癌亚型和向蛋白质的PROTACs分类.
主要成果:
- PROTACs通过劫持细胞的天然蛋白质降解机制来消除标蛋白质而起作用.
- 这种方法可以降解以前被认为是无毒的蛋白质,提供新的治疗途径.
- 目前的PROTAC研究表明,由于它们的催化性质,在低剂量下具有高疗效的潜力.
结论:
- PROTACs代表了一种具有重大潜力的开创性治疗策略,用于治疗各种类型的乳腺癌.
- 需要进一步的研究来克服现有的局限性,并充分认识到PROTACs在BC治疗中的临床实用性.
- 该审查强调了PROTACs在精密瘤学中的不断变化的作用,以及它们对抗乳腺癌的未来前景.
更多相关视频
05:33High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
9.5K
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.7K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K